CACNA2D2

Across TCGA pan-cancer cohorts, CACNA2D2 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CACNA2D2 data layer compared with 26 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CACNA2D2 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated CACNA2D2 expression acts as an unfavorable survival marker, although some lineages such as LUAD and PDAC show a favorable association.

LUAD, HNSC, and PDAC are the cancer types where CACNA2D2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Quartile	All	0.888	0.505	.002	21	view →
HNSC	OS	Tertile	III,IV	0.419	1.000	.038	2	view →
PDAC	OS	Quartile	II,III,IV	1.000	0.665	.011	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

CACNA2D2–LUAD (DFS)

Open the LUAD breakdown →